EUVIMEDEUVIMED entdecken
Crossref

Anti-U1-RNP antibody positivity is associated with elevated interferon-stimulated gene expression scores in systemic lupus erythematosus irrespective of disease activity: a transcriptome analysis in Japanese patients

Takemichi Matsui, Yumi Tsuchida iD, Takahiro Itamiya, Mineto Ota, Toshihiko Komai, Haruka Tsuchiya, Hirofumi Shoda, Tomohisa Okamura, Keishi Fujio

Modern Rheumatology · 2025

DOI: 10.1093/mr/roaf066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Takemichi Matsui und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Ribonucleoprotein, U1 Small Nuclear, Autoantibodies, Antibodies, Antinuclear. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C), Center of Innovation Program from the Japan Science and Technology Agency (JST), Ministry of Education, Culture, Sports, and the Japan Agency for Medical Research and Development (AMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

With the introduction of anifrolumab to clinical practice, there is a growing interest in identifying factors associated with interferon (IFN) activity in patients with systemic lupus erythematosus (SLE). An association between IFN-stimulated gene (ISG) expression and anti-U1-ribonucleoprotein (RNP) antibody positivity has been reported. However, data from Asians are scarce. In this study, we investigated clinical parameters associated with ISG expression in patients with SLE in Japan.

Methods

We utilized transcriptome data from 130 Japanese patients diagnosed with SLE from the ImmuNexUT database. We defined the ISG score as the average normalized expression levels of IFI27, IFI44, IFI44L, and RSAD2. The associations between clinical parameters and the ISG score were assessed.

Results

Clinical characteristics were compared between the low- and high-ISG-score groups. Clinical SLE disease activity index, anti-U1-RNP antibodies, and anti-Sjogren's syndrome antigen A (SS-A) antibodies were associated with the high-ISG-score group in multiple logistic regression analysis. Classification and regression tree analysis indicated that anti-U1-RNP antibody positivity was the best serological factor predicting the ISG score. Even among patients with clinically inactive disease, the ISG score was higher in those positive for than in those negative for anti-U1-RNP antibodies.

Conclusions

Autoantibody profiles, especially anti-U1-RNP antibodies, are useful for predicting ISG scores in Asians.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicRibonucleoprotein, U1 Small NuclearAutoantibodiesAntibodies, AntinuclearHumansFemaleMaleAdultMiddle AgedJapanGene Expression ProfilingSeverity of Illness IndexTranscriptomeInterferonsMembrane ProteinsAntigensCytoskeletal ProteinsTumor Suppressor ProteinsEast Asian People

Stichwörter der Autor:innen

Systemic lupus erythematosusanti-U1-RNP antibodiesinterferons

Substanzen

Ribonucleoprotein, U1 Small NuclearIFI44 protein, humanIFI27 protein, humanAutoantibodiesAntibodies, AntinuclearIFI44L protein, humanInterferonsMembrane ProteinsAntigensCytoskeletal Proteins

Autor:innen und Institutionen

  • Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Yumi Tsuchida

Förderung

  • Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C)
  • Center of Innovation Program from the Japan Science and Technology Agency (JST)
  • Ministry of Education, Culture, Sports, and the Japan Agency for Medical Research and Development (AMED)
  • Ministry of Education, Culture, Sports, and the Japan AMED
  • Chugai Pharmaceutical Co., Ltd, Tokyo, Japan

Zitieren

APA

Matsui, T., Tsuchida, Y., Itamiya, T., Ota, M., Komai, T., Tsuchiya, H., Shoda, H., Okamura, T., & Fujio, K. (2025). Anti-U1-RNP antibody positivity is associated with elevated interferon-stimulated gene expression scores in systemic lupus erythematosus irrespective of disease activity: a transcriptome analysis in Japanese patients. Modern Rheumatology. https://doi.org/10.1093/mr/roaf066

Vancouver

Matsui T, Tsuchida Y, Itamiya T, Ota M, Komai T, Tsuchiya H, et al. Anti-U1-RNP antibody positivity is associated with elevated interferon-stimulated gene expression scores in systemic lupus erythematosus irrespective of disease activity: a transcriptome analysis in Japanese patients. Modern Rheumatology. 2025. doi:10.1093/mr/roaf066

BibTeX
@article{Matsui2025,
  author = {Matsui, Takemichi and Tsuchida, Yumi and Itamiya, Takahiro and Ota, Mineto and Komai, Toshihiko and Tsuchiya, Haruka and Shoda, Hirofumi and Okamura, Tomohisa and Fujio, Keishi},
  title = {Anti-U1-RNP antibody positivity is associated with elevated interferon-stimulated gene expression scores in systemic lupus erythematosus irrespective of disease activity: a transcriptome analysis in Japanese patients},
  journal = {Modern Rheumatology},
  year = {2025},
  doi = {10.1093/mr/roaf066}
}
Kostenlos starten →